Eine zielgenaue Bewerbung für diesen Job — ein maßgeschneiderter Lebenslauf und ein Anschreiben, die genau zur Stellenanzeige passen.
Evotec is seeking a Manager Group Consolidation & Reporting (all genders) for its Hamburg headquarters to lead the group consolidation and IFRS reporting, including notes and management reporting for Evotec Group.
You will coordinate year-end and quarterly audits with external auditors, collaborate with subsidiaries across countries, review reporting packages for data quality, and drive process improvements in consolidation and the Onestream platform.
We are currently seeking for our Headquarter in Hamburg a highly motivated and dedicated Manager Group Consolidation & Reporting (all genders) Full-time and permanent.
FR : Dans le cadre de sa politique Diversité, Evotec étudie, à compétences égales, toutes les candidatures dont celles des personnes en situation de handicap.
ENG : In the frame of our Diversity policy, Evotec considers, with equal competences, all applications including people with disabilities.
Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients.
The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products.
Evotec leverages this Data-driven R&D Autobahn to Cures for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders.
Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.
Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of more than 200 proprietary and co-owned R&D projects from early discovery to clinical development.
Evotec operates globally with more than 5,000 highly qualified people. The Company’s 17 sites offer highly synergistic technologies and services and operate as complementary clusters of excellence.
For additional information please go to www.evotec.com and follow us on X/Twitter @Evotec and LinkedIn.